Literature DB >> 8706329

Immunoregulation in onchocerciasis: predominance of Th1-type responsiveness to low molecular weight antigens of Onchocerca volvulus in exposed individuals without microfilaridermia and clinical disease.

C G Lüder1, H Schulz-Key, M Banla, S Pritze, P T Soboslay.   

Abstract

Chronic and generalized onchocerciasis is associated with suppression of the parasite-specific cellular responsiveness, while exposed individuals without parasitological and clinical evidence of infection (endemic normals) display prominent cellular reactivity to Onchocerca volvulus antigens (OvAg). In order to identify those parasite antigens which may account for this differential cellular responsiveness, total adult worm-derived OvAg were fractionated by means of preparative SDS-PAGE and blot-elution into 22 antigen fractions of continuously decreasing molecular weight. Peripheral blood mononuclear cells (PBMC) from microfilariae (mf)-positive onchocerciasis patients (n = 18) proliferated weakly in response to all OvAg fractions. In contrast, in vitro reactivity of PBMC from endemic normals (n = 9) was depressed in response to OvAg of mol. wt 200-30 kD only, while antigens of mol. wt < 30 kD induced vigorous proliferation in these individuals compared with the microfilaridermic patients (P < 0.05). Highest proliferative reactivity of cells from endemic normals was observed in response to OvAg of mol. wt 15-11 kD. Furthermore, these low mol. wt antigen fractions induced substantial production of IL-2 and interferon-gamma (IFN-gamma) in PBMC from endemic normals, but not in those from onchocerciasis patients. Cells from individuals of both groups secreted similar amounts of IL-5 in response to all OvAg fractions, with highest production again being induced by low mol. wt OvAg. In contrast, PBMC from onchocerciasis patients clearly produced more IL-10 than did cells from endemic normals. This augmented IL-10 production by PBMC from mf-positive individuals was not only observed after stimulation with OvAg fractions, but was measured in unstimulated control cultures as well. IFN-gamma-specific mRNA in antigen-stimulated PBMC from endemic normals appeared to be more prominent than in cells from onchocerciasis patients. However, mRNA transcripts of IL-10 and IL-13 were clearly present in patients, but were absent or inconsistently observed in endemic normals. Our results suggest that vigorous Th1-type cellular responsiveness encountered in endemic normals is restricted to low mol. wt antigens of O. volvulus, while such reactivity will not be present in mf-positive individuals. Furthermore, spontaneous production of high levels of IL-10 in onchocerciasis patients is likely to suppress Th1-type immunity, and thus may favour manifestation of chronic onchocerciasis. These traits of cellular immunity may contribute to the differential outcome of O. volvulus infection, the manifestation of clinical disease, and may also regulate the build up of acquired immunity in humans.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8706329      PMCID: PMC2200496          DOI: 10.1046/j.1365-2249.1996.d01-747.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  11 in total

1.  The diverse expression of immunity in humans at distinct states of Onchocerca volvulus infection.

Authors:  P T Soboslay; S M Geiger; N Weiss; M Banla; C G Lüder; C M Dreweck; E Batchassi; B A Boatin; A Stadler; H Schulz-Key
Journal:  Immunology       Date:  1997-04       Impact factor: 7.397

2.  Interleukin-12 modulates T-cell responses to microfilariae but fails to abrogate interleukin-5-dependent immunity in a mouse model of onchocerciasis.

Authors:  P J Hogarth; A E Bianco
Journal:  Immunology       Date:  1999-11       Impact factor: 7.397

3.  Molecular characterization and evaluation of Onchocerca volvulus-secreted larval acidic protein 1 (SLAP1) as a putative vaccine candidate on endemic population of lymphatic filariasis.

Authors:  Natarajan Mahalakshmi; Ramanathan Aparnaa; Lawrance Ansel Vishal; Perumal Kaliraj
Journal:  Parasitol Res       Date:  2013-07-05       Impact factor: 2.289

4.  Prenatal immune priming in onchocerciasis-onchocerca volvulus-specific cellular responsiveness and cytokine production in newborns from infected mothers.

Authors:  P T Soboslay; S M Geiger; B Drabner; M Banla; E Batchassi; L A Kowu; A Stadler; H Schulz-Key
Journal:  Clin Exp Immunol       Date:  1999-07       Impact factor: 4.330

5.  Development of a recombinant antigen vaccine against infection with the filarial worm Onchocerca volvulus.

Authors:  D Abraham; O Leon; S Leon; S Lustigman
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

6.  Phosphocholine-containing, zwitterionic glycosphingolipids of adult Onchocerca volvulus as highly conserved antigenic structures of parasitic nematodes.

Authors:  M Wuhrer; S Rickhoff; R D Dennis; G Lochnit; P T Soboslay; S Baumeister; R Geyer
Journal:  Biochem J       Date:  2000-06-01       Impact factor: 3.857

7.  Immunity to onchocerciasis: cells from putatively immune individuals produce enhanced levels of interleukin-5, gamma interferon, and granulocyte-macrophage colony-stimulating factor in response to Onchocerca volvulus larval and male worm antigens.

Authors:  P S Turaga; T J Tierney; K E Bennett; M C McCarthy; S C Simonek; P A Enyong; D W Moukatte; S Lustigman
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

8.  Presence of phosphorylcholine on a filarial nematode protein influences immunoglobulin G subclass response to the molecule by an interleukin-10-dependent mechanism.

Authors:  K M Houston; E H Wilson; L Eyres; F Brombacher; M M Harnett; J Alexander; W Harnett
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

9.  Biochemical characterization and evaluation of a Brugia malayi small heat shock protein as a vaccine against lymphatic filariasis.

Authors:  Gajalakshmi Dakshinamoorthy; Abhilash Kumble Samykutty; Gnanasekar Munirathinam; Gangadhar Bhaurao Shinde; Thomas Nutman; Maryada Venkatarami Reddy; Ramaswamy Kalyanasundaram
Journal:  PLoS One       Date:  2012-04-05       Impact factor: 3.240

10.  Onchocerca volvulus-specific antibody and cellular responses in onchocerciasis patients treated annually with ivermectin for 30 years and exposed to parasite transmission in central Togo.

Authors:  Saskia I Johanns; Richard G Gantin; Bawoubadi Wangala; Kossi Komlan; Wemboo A Halatoko; Meba Banla; Potchoziou Karabou; Adrian Jf Luty; Hartwig Schulz-Key; Carsten Köhler; Peter T Soboslay
Journal:  PLoS Negl Trop Dis       Date:  2022-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.